- 专利标题： Halo-substituted piperidines as orexin receptor modulators
-
申请号： US17868856申请日： 2022-07-20
-
公开(公告)号： US12084437B2公开(公告)日： 2024-09-10
- 发明人: Theodore M. Kamenecka , Jörg Holenz , Steven Wesolowski , Yuanjun He , Roland Bürli
- 申请人： AstraZeneca AB , EOLAS THERAPEUTICS, INC.
- 申请人地址： SE CA Södertälje
- 专利权人： ASTRAZENECA AB,EOLAS THERAPEUTICS, INC
- 当前专利权人： ASTRAZENECA AB,EOLAS THERAPEUTICS, INC
- 当前专利权人地址： SE Södertälje; US CA Carlsbad
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61P25/34 ; C07D401/14 ; C07D409/14 ; C07D413/14 ; C07D417/14
摘要：
The present application relates to certain halo-substituted piperidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension.
公开/授权文献
信息查询
IPC分类:
